Rexall Sundown Inc., a leading manufacturer of vitamins and dietary supplements, agreed to pay up to $12 million to settle a federal suit that accused it of making exaggerated claims about Cellasene, a product the company said substantially reduced cellulite.

“Hundreds of thousands of consumers were misled by claims for this product,” said Howard Beales, director of the FTC’s Bureau of Consumer Protection.

The pills did not eliminate or substantially reduce cellulite as Rexall claimed, the FTC charged.

“We maintain that we adhered to the applicable standard in the promotion and sale of Cellasene,” said company spokeswoman Carol Walters, adding that Tuesday’s settlement agreement is in no way an admission of wrongdoing on the part of Rexall Sundown.

“We just wished to move forward and start looking to the future,” she said.

(via The Palm Beach Post)